Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Return on Invested Capital (2016 - 2025)

Dexcom (DXCM) has disclosed Return on Invested Capital for 12 consecutive years, with 0.26% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital rose 2.0% to 0.26% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.26% through Dec 2025, up 2.0% year-over-year, with the annual reading at 0.29% for FY2025, 6.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.26% at Dexcom, up from 0.22% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.36% in Q1 2021, with the low at 0.11% in Q2 2022.
  • Average Return on Invested Capital over 5 years is 0.21%, with a median of 0.21% recorded in 2023.
  • Peak annual rise in Return on Invested Capital hit 16bps in 2021, while the deepest fall reached -25bps in 2021.
  • Over 5 years, Return on Invested Capital stood at 0.11% in 2021, then surged by 52bps to 0.17% in 2022, then rose by 22bps to 0.21% in 2023, then grew by 14bps to 0.24% in 2024, then grew by 7bps to 0.26% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.26%, 0.22%, and 0.21% for Q4 2025, Q3 2025, and Q2 2025 respectively.